Role of Fks1p and Matrix Glucan in Candida albicans Biofilm Resistance to an Echinocandin, Pyrimidine, and Polyene

被引：149

作者：

Nett, Jeniel E. ^{[1
,3
]}

Crawford, Kyler ^{[1
]}

Marchillo, Karen ^{[1
]}

Andes, David R. ^{[1
,2
]}

机构：

[1] Univ Wisconsin, Dept Med, Madison, WI 53792 USA

[2] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53792 USA

[3] Univ Wisconsin, Dept Cellular & Mol Biol, Madison, WI 53792 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2010年 / 54卷 / 08期

基金：

美国国家卫生研究院;

关键词：

IN-VITRO; FLUCONAZOLE RESISTANCE; ANTIFUNGAL AGENTS; DRUG-RESISTANCE; EFFLUX PUMPS; IDENTIFICATION; GENE;

D O I：

10.1128/AAC.00227-10

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Candida infections frequently involve drug-resistant biofilm growth on device surfaces. Glucan synthase gene FKS1 has been linked to triazole resistance in Candida biofilms. We tested the impact of FKS1 modulation on susceptibility to additional antifungal classes. Reduction of FKS1 expression rendered biofilms more susceptible to amphotericin B, anidulafungin, and flucytosine. Increased resistance to anidulafungin and amphotericin B was observed for biofilms overexpressing FKS1. These findings suggest that Candida biofilm glucan sequestration is a multidrug resistance mechanism.

引用

页码：3505 / 3508

页数：4

共 23 条

[1] Biofilm matrix of Candida albicans and Candida tropicalis:: chemical composition and role in drug resistance [J].

Al-Fattani, Mohammed A. ;

Douglas, L. Julia .

JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 55 (08) :999-1008

[2] Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents [J].

Baillie, GS ;

Douglas, LJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :1900-1905

[3] Biofilm formation by the fungal pathogen Candida albicans:: Development, architecture, and drug resistance [J].

Chandra, J ;

Kuhn, DM ;

Mukherjee, PK ;

Hoyer, LL ;

McCormick, T ;

Ghannoum, MA .

JOURNAL OF BACTERIOLOGY, 2001, 183 (18) :5385-5394

[4] RIM101-dependent and -independent pathways govern pH responses in Candida albicans [J].

Davis, D ;

Wilson, RB ;

Mitchell, AP .

MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (03) :971-978

[5] Biofilm formation: A clinically relevant microbiological process [J].

Donlan, RM .

CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) :1387-1392

[6] Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors [J].

Douglas, CM ;

DIppolito, JA ;

Shei, GJ ;

Meinz, M ;

Onishi, J ;

Marrinan, JA ;

Li, W ;

Abruzzo, GK ;

Flattery, A ;

Bartizal, K ;

Mitchell, A ;

Kurtz, MB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) :2471-2479

[7] Candida biofilms and their role in infection [J].

Douglas, LJ .

TRENDS IN MICROBIOLOGY, 2003, 11 (01) :30-36

[8] Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints [J].

Garcia-Effron, Guillermo ;

Park, Steven ;

Perlin, David S. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (01) :112-122

[9] BIOFILM FORMATION BY CANDIDA SPECIES ON THE SURFACE OF CATHETER MATERIALS IN-VITRO [J].

HAWSER, SP ;

DOUGLAS, LJ .

INFECTION AND IMMUNITY, 1994, 62 (03) :915-921

[10] Candida infections of medical devices [J].

Kojic, EM ;

Darouiche, RO .

CLINICAL MICROBIOLOGY REVIEWS, 2004, 17 (02) :255-+

← 1 2 3 →